Advisor Group’s enVVeno Medical NVNO Stock Holding History

Advisor Group’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$8K	Hold	17	–	–	﹤0.01%	4461
2019 Q3	$13K	Buy	+17	New	+$14.8K	﹤0.01%	4209

Other funds holding NVNO

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

GIA

Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group's NVNO Position: Q4 2019 in Review

Advisor Group held its enVVeno Medical (NVNO) position steady in Q4 2019 at 17 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #4461.

Advisor Group first reported a position in NVNO in Q3 2019 and has held it in 2 quarters since. The position peaked at $13K in Q3 2019. 6 funds tracked by Wall St. Rank hold NVNO as of Q4 2019.

Advisor Group held 17 shares of enVVeno Medical worth $8K as of Q4 2019.
Advisor Group left its enVVeno Medical share count unchanged in Q4 2019.
enVVeno Medical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4461 holding.
Advisor Group first reported a position in enVVeno Medical in Q3 2019 and has held it in 2 quarters since.
Advisor Group's enVVeno Medical position peaked at $13K in Q3 2019.
6 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.